HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.

Abstract
Microvascular insufficiency contributes to cardiac hypertrophy and worsens heart dysfunction in diabetic cardiomyopathy. Our recent study shows that apelin may protect ischemic heart failure via upregulation of sirtuin 3 (Sirt3) and angiogenesis. This study investigated whether apelin promotes angiogenesis and ameliorates diabetic cardiomyopathy via activation of Sirt3. Wild-type (WT) and diabetic db/db mice were administrated with adenovirus-apelin to overexpressing apelin. In WT mice, overexpression of apelin increased Sirt3, VEGF/VEGFR2, and angiopoietin-1 (Ang-1)/Tie-2 expression in the heart. In vitro, treatment of endothelial cells (EC) with apelin increased VEGF and Ang-1 expression. In EC isolated from Sirt3KO mice, however, apelin treatment did not upregulate VEGF and Ang-1 expression. Moreover, apelin-induced angiogenesis was diminished in Sirt3KO mice. In db/db mice, the basal levels of apelin and Sirt3 expression were significantly reduced in the heart. This was accompanied by a significant reduction of capillary and arteriole densities in the heart. Overexpression of apelin increased Sirt3, VEGF/VEGFR2, and Ang-1/Tie-2 expression together with improved vascular density in db/db mice. Overexpression of apelin further improved cardiac function in db/db mice. Treatment with apelin significantly attenuated high glucose (HG)-induced reactive oxygen species (ROS) formation and EC apoptosis. The protection of apelin against HG-induced ROS formation and EC apoptosis was diminished in Sirt3KO-EC. We conclude that apelin gene therapy increases vascular density and alleviates diabetic cardiomyopathy by a mechanism involving activation of Sirt3 and upregulation of VEGF/VEGFR2 and Ang-1/Tie-2 expression.
AuthorsHeng Zeng, Xiaochen He, Xuwei Hou, Lanfang Li, Jian-Xiong Chen
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 306 Issue 4 Pg. H585-97 (Feb 15 2014) ISSN: 1522-1539 [Electronic] United States
PMID24363305 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Adipokines
  • Angiopoietin-1
  • Angiopoietin-2
  • Apelin
  • Apln protein, mouse
  • Intercellular Signaling Peptides and Proteins
  • Reactive Oxygen Species
  • Vascular Endothelial Growth Factor A
  • Receptor, TIE-2
  • Receptors, Vascular Endothelial Growth Factor
  • Sirtuin 3
Topics
  • Adipokines
  • Angiopoietin-1 (genetics, metabolism)
  • Angiopoietin-2 (metabolism)
  • Animals
  • Apelin
  • Apoptosis (physiology)
  • Diabetic Cardiomyopathies (genetics, metabolism, physiopathology, therapy)
  • Endothelium, Vascular (metabolism, physiopathology)
  • Heart (physiopathology)
  • Intercellular Signaling Peptides and Proteins (genetics)
  • Male
  • Mice
  • Myocardium (metabolism)
  • Neovascularization, Pathologic (genetics, metabolism, physiopathology, therapy)
  • Reactive Oxygen Species (metabolism)
  • Receptor, TIE-2 (genetics, metabolism)
  • Receptors, Vascular Endothelial Growth Factor (genetics, metabolism)
  • Sirtuin 3 (genetics, metabolism)
  • Up-Regulation (genetics)
  • Vascular Endothelial Growth Factor A (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: